Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Pressure Ulcers - Pipeline Review, H2 2018
... landscape. Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large ... Read More
-
Alopecia - Pipeline Review, H2 2018
... the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, ... Read More
-
Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
... 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately ... Read More
-
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
... report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline ... Read More
-
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
... or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 ... Read More
-
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
... by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response ... Read More
-
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
... Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the ... Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q3 2018
... impact on the healthcare andpharmaceutical opportunities in the country. Increased public sector funding should significantly reduce the over-reliance on out-of-pocket payments, footed by the, generally speaking, low-income population. The country's demographic profile also doesprovide commercial ... Read More
-
The 2019-2024 Outlook for Pain Management Products and Services in the United States
... States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is ... Read More
-
The 2019-2024 Outlook for Asthma Therapeutics in the United States
... U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the ... Read More
-
The 2019-2024 Outlook for Anti-Migraine Drugs in the United States
... U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the ... Read More
-
The 2019-2024 Outlook for Epilepsy Drugs in the United States
... U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the ... Read More
-
Laos Pharmaceuticals & Healthcare Q3 2018
... to act as key drivers of market growth. Meanwhile, the government will remain committed to improving the regulatoryand business environment. That said, the small domestic drug market, combined with low spending per capita on medicine ... Read More
-
The 2019-2024 Outlook for Hepatitis Drugs in the United States
... U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the ... Read More
-
Venezuela Pharmaceuticals & Healthcare Q3 2018
... for drugmakers.Despite once being an economically prospering country, Venezuela now has restricted funds available for healthcare spending. Thiswill continue to have an impact on medicine affordability, which compounded with hyperinflation, depreciated bolivar andreduced drugmaker activities ... Read More
-
Mexico Orthopedic Prosthetics Procedures Outlook to 2025
... market segments - Amputation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information ... Read More
-
The 2019-2024 Outlook for Botanical Supplements in the United States
... U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the ... Read More
-
The 2019-2024 Outlook for Nutritional Premixes in the United States
... U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the ... Read More
-
MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
... Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response ... Read More
-
Austria Pharmaceuticals & Healthcare Q3 2018
... incomparison to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More
-
Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
... - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY ... Read More
-
Italy Orthopedic Prosthetics Procedures Outlook to 2025
... market segments - Amputation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information ... Read More
-
Botswana Pharmaceuticals & Healthcare Q3 2018
... by a weakregulatory environment, small pensionable population and a highly ruralised community. Generic medicines will continue todominate the market, with patented drugmakers choosing to operate in larger markets in the region such as South African. Read More
-
Costa Rica Pharmaceuticals & Healthcare Q3 2018
... and development opportunities tomultinationals, based on factors such as continuous improvement in healthcare infrastructure and government commitment toupholding an attractive business environment. Additionally, the demand for innovative medicines will still need to be met through ... Read More
-
Japan Orthopedic Prosthetics Procedures Outlook to 2025
... market segments - Amputation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information ... Read More
